| langue originale | Anglais |
|---|---|
| Pages (de - à) | 281-282 |
| Nombre de pages | 2 |
| journal | Annals of Oncology |
| Volume | 29 |
| Numéro de publication | 1 |
| Les DOIs | |
| état | Publié - 1 janv. 2018 |
Accès au document
Autres fichiers et liens
Contient cette citation
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver
}
Dans: Annals of Oncology, Vol 29, Numéro 1, 01.01.2018, p. 281-282.
Résultats de recherche: Contribution à un journal › Letter › Revue par des pairs
TY - JOUR
T1 - Reply to 'the St Gallen international expert consensus on the primary therapy of early breast cancer 2017
T2 - Te point of view of an international panel of experts in radiation oncology' by Kirova et al.
AU - on behalf of the Panel Members of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2017
AU - Dubsky, P.
AU - Curigliano, G.
AU - Burstein, H. J.
AU - Winer, E. P.
AU - Gnant, M.
AU - Loibl, S.
AU - Colleoni, M.
AU - Regan, M. M.
AU - Piccart-Gebhart, M.
AU - Senn, H. J.
AU - Thrlimann, B.
AU - André, F.
AU - Baselga, J.
AU - Bergh, J.
AU - Bonnefoi, H.
AU - Brucker, S. Y.
AU - Cardoso, F.
AU - Carey, L.
AU - Ciruelos, E.
AU - Cuzick, J.
AU - Denkert, C.
AU - Di Leo, A.
AU - Ejlertsen, B.
AU - Francis, P.
AU - Galimberti, V.
AU - Garber, J.
AU - Gulluoglu, B.
AU - Goodwin, P.
AU - Harbeck, N.
AU - Hayes, D. F.
AU - Huang, C. S.
AU - Huober, J.
AU - Khaled, H.
AU - Jassem, J.
AU - Jiang, Z.
AU - Karlsson, P.
AU - Morrow, M.
AU - Orecchia, R.
AU - Osborne, K. C.
AU - Pagani, O.
AU - Partridge, A. H.
AU - Pritchard, K.
AU - Ro, J.
AU - Rutgers, E. J.T.
AU - Sedlmayer, F.
AU - Semiglazov, V.
AU - Shao, Z.
AU - Smith, I.
AU - Toi, M.
AU - Tutt, A.
N1 - Funding Information: P. Dubsky1,2*, G. Curigliano3, H. J. Burstein4, E. P. Winer4, M. Gnant1, S. Loibl5, M. Colleoni3, M. M. Regan6, M. Piccart-Gebhart7, H.-J. Senn8 &B.Thürlimann9,onbehalfofthePanelMembersoftheStGallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2017 F. André10, J. Baselga11, J. Bergh12, H. Bonnefoi13, S. Y. Brucker14, F. Cardoso15, L. Carey16, E. Ciruelos17, J. Cuzick18, C. Denkert19, A. Di Leo20, B. Ejlertsen21, P. Francis22, V. Galimberti1, J. Garber2, B. Gulluoglu23, P. Goodwin24, N. Harbeck25, D. F. Hayes26, C.-S. Huang27, J. Huober28, H. Khaled29, J. Jassem30, Z. Jiang31, P. Karlsson32, M. Morrow11, R. Orecchia1, K. C. Osborne33, O. Pagani34, A. H. Partridge2, K. Pritchard35,J. Ro36, E. J. T. Rutgers37, F. Sedlmayer38, V. Semiglazov39, Z. Shao40, I. Smith41, M. Toi42, A. Tutt43, G. Viale44,45, T. Watanabe46, T. J. Whelan47 &B.Xu48 1Comprehensive Cancer Center Vienna, Medical University of Vienna, Vienna, Austria; 2Klinik St. Anna, Luzern, Switzerland; 3Breast Cancer Program, Istituto Europeo di Oncologia, Milan, Italy; 4Breast Oncology Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, USA; 5German Breast Group, Neu-Isenburg, Germany; 6Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, USA; 7Institut Jules Bordet, Bruxelles, Belgium; 8Tumor and Breast Center ZeTuP, St Gallen; 9Breast Center, Kantonsspital St. Gallen, St Gallen, Switzerland; 10Institut de Cancérologie Gustave Roussy, Villejuif, France; 11Memorial Sloan Kettering Cancer Center, New York, USA; 12Karolinska Institute and University Hospital, Stockholm, Sweden; 13University of Bordeaux, Bordeaux,France;14Universit€ats-FrauenklinikTübingen,Tübingen, Germany; 15Champalimaud Cancer Centre, Lisbon, Portugal; 16Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, USA; 17Hospital Universitario 12 de Octubre, Madrid, Spain; 18Centre for Cancer Prevention, Wolfson Institute of Preventive Medicine, Queen Mary University of London, London, UK; 19Institut für Pathologie, Charité Universit€atsmedizin Berlin, Berlin, Germany; 20Azienda Usl Toscana Centro, Prato, Italy; 21Rigshospitalet, Copenhagen, Denmark; 22Peter McCallum Cancer Centre, Melbourne, Australia; 23Marmara University School of Medicine, Istanbul, Turkey; 24University of Toronto, Mount Sinai Hospital, Toronto, Canada; 25UniversityofMunich,München,Germany;26ComprehensiveCancer Center, University of Michigan, Ann-Arbor, USA; 27National Taiwan University Hospital, Taipei, Taiwan; 28University of Ulm, Ulm, Germany; 29The National Cancer Institute, Cairo University, Cairo, Egypt; 30Medical University of Gdansk, Gdansk, Poland;31Hospital Affiliated to Military Medical Science, Beijing, China; 32Institute of Clinical Sciences, Sahlgrenska Academy, Sahlgrensky University Hospital, Gothenburg, Sweden; 33Baylor College of Medicine, Houston, USA; 34Institute of Oncology Southern Switzerland, Ospedale San Giovanni, Bellinzona, Switzerland; 35University of Toronto, Sunnybrook Odette Cancer Center, Toronto, Canada; 36National Cancer Center, Ilsandong-gu, Goyang-si, Gyeonggi-do, Korea; 37Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands; 38LKH Salzburg, Paracelsus Medical University Clinics, Salzburg, Austria; 39N.N.Petrov Research Institute of Oncology, St. Petersburg, Russian Federation; 40Fudan University Cancer Hospital, Shanghai, China;41The Royal Marsden, Sutton, Surrey, UK; 42Graduate
PY - 2018/1/1
Y1 - 2018/1/1
UR - http://www.scopus.com/inward/record.url?scp=85041238528&partnerID=8YFLogxK
U2 - 10.1093/annonc/mdx543
DO - 10.1093/annonc/mdx543
M3 - Letter
C2 - 29045519
AN - SCOPUS:85041238528
SN - 0923-7534
VL - 29
SP - 281
EP - 282
JO - Annals of Oncology
JF - Annals of Oncology
IS - 1
ER -